CURE.XETRA VanEck Genomics and Healthcare Innovators UCITS ETF EUR

ETF Healthcare Equity VanEck Asset Management B.V. XETRA Stock Exchange
- EUR
No recent price
Total assets
24.4M
Expense ratio
-
Dividend yield
0.09%
1-year return
+33.94%
Holdings
10
Since
2022

Fund data as reported by the issuer, updated Nov 6, 2026. Total assets are in the fund's base currency.

What does CURE.XETRA invest in?

Tracks Morningstar Gbl Health NR USD
  • Mostly US stocks (91.5%)
  • Largest sector: Healthcare (96.2%)
  • Largest region: North America (91.5%)
  • Top 3 holdings: 23.3% of the fund

Asset allocation

  • US stocks 91.5%
  • Non-US stocks 9.4%

Top holdings

All holdings, sectors and regions

VanEck Genomics and Healthcare Innovators UCITS ETF EUR performance

Sharpe ratio 0.84
This year
+31.05%
1 year
+33.94%
3 years
+15.20%
5 years
0.00%

Volatility 24.5% over 1 year and 19.5% over 3 years. Moderate, similar to a broad stock index.

Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers

CURE.XETRA price

Prices on the chart can differ slightly from the closing prices StockSummer shows.